[TENAGA] QoQ Cumulative Quarter Result on 30-Jun-2023 [#2]

Announcement Date
25-Aug-2023
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2023
Quarter
30-Jun-2023 [#2]
Profit Trend
QoQ- 32.71%
YoY- -24.65%
Quarter Report
View:
Show?
Cumulative Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 13,640,400 53,066,900 39,414,900 25,948,800 12,625,600 50,867,700 53,872,200 -59.94%
PBT 1,029,800 3,373,600 2,699,700 1,644,200 1,102,700 5,348,600 4,531,900 -62.72%
Tax -351,900 -770,000 -620,500 -442,400 -171,800 -1,791,200 -1,782,400 -66.06%
NP 677,900 2,603,600 2,079,200 1,201,800 930,900 3,557,400 2,749,500 -60.64%
-
NP to SH 715,700 2,770,300 2,186,400 1,330,200 1,002,300 3,463,300 2,654,200 -58.22%
-
Tax Rate 34.17% 22.82% 22.98% 26.91% 15.58% 33.49% 39.33% -
Total Cost 12,962,500 50,463,300 37,335,700 24,747,000 11,694,700 47,310,300 51,122,700 -59.90%
-
Net Worth 57,946,818 58,668,477 57,761,953 57,994,981 57,847,770 58,367,948 57,290,902 0.76%
Dividend
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Div - 2,655,047 1,037,992 1,036,097 - 2,639,681 1,146,701 -
Div Payout % - 95.84% 47.47% 77.89% - 76.22% 43.20% -
Equity
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Net Worth 57,946,818 58,668,477 57,761,953 57,994,981 57,847,770 58,367,948 57,290,902 0.76%
NOSH 5,787,331 5,787,331 5,787,331 5,787,331 5,753,077 5,753,077 5,753,077 0.39%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin 4.97% 4.91% 5.28% 4.63% 7.37% 6.99% 5.10% -
ROE 1.24% 4.72% 3.79% 2.29% 1.73% 5.93% 4.63% -
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
RPS 235.69 919.41 683.50 450.81 219.46 886.44 939.60 -60.19%
EPS 12.37 48.00 37.91 23.11 17.42 60.35 46.29 -58.47%
DPS 0.00 46.00 18.00 18.00 0.00 46.00 20.00 -
NAPS 10.0127 10.1646 10.0166 10.0754 10.0551 10.1714 9.9923 0.13%
Adjusted Per Share Value based on latest NOSH - 5,787,331
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
RPS 235.30 915.43 679.93 447.63 217.80 877.49 929.32 -59.94%
EPS 12.35 47.79 37.72 22.95 17.29 59.74 45.79 -58.22%
DPS 0.00 45.80 17.91 17.87 0.00 45.54 19.78 -
NAPS 9.9961 10.1206 9.9642 10.0044 9.979 10.0688 9.883 0.76%
Price Multiplier on Financial Quarter End Date
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Date 29/03/24 29/12/23 29/09/23 30/06/23 31/03/23 30/12/22 30/09/22 -
Price 11.38 10.04 9.99 9.05 9.23 9.63 8.05 -
P/RPS 4.83 1.09 1.46 2.01 4.21 1.09 0.86 215.62%
P/EPS 92.02 20.92 26.35 39.16 52.98 15.96 17.39 203.35%
EY 1.09 4.78 3.80 2.55 1.89 6.27 5.75 -66.96%
DY 0.00 4.58 1.80 1.99 0.00 4.78 2.48 -
P/NAPS 1.14 0.99 1.00 0.90 0.92 0.95 0.81 25.56%
Price Multiplier on Announcement Date
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Date 31/05/24 27/02/24 24/11/23 25/08/23 29/05/23 27/02/23 23/11/22 -
Price 13.04 11.42 10.00 9.97 9.75 9.64 8.42 -
P/RPS 5.53 1.24 1.46 2.21 4.44 1.09 0.90 235.10%
P/EPS 105.44 23.79 26.37 43.14 55.96 15.97 18.19 222.34%
EY 0.95 4.20 3.79 2.32 1.79 6.26 5.50 -68.95%
DY 0.00 4.03 1.80 1.81 0.00 4.77 2.38 -
P/NAPS 1.30 1.12 1.00 0.99 0.97 0.95 0.84 33.76%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment